News for Sorrento Therapeutics, Inc. (0L85.L)

Published at

Oct 29, 2024 11:00 AM

by globenewswire.com

positive

positive

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative

Scilex management is determined to enhance its stockholders’ value and protect their stockholder rights, and is taking steps to combat manipulative and...

SRNE BR B1RF34.SA 0L85.L

Read more →
Published at

Oct 15, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain

Prostate cancer is one of the most common cancers among men worldwide, especially in aging populations. The increasing global elderly population leads to...

FUSN LLY.MX LLY.DE LLY.BA LLY LILY34.SA JANX 0Q1G.L SRNE BTAI BNTXN.MX BNTX 0L85.L 0A3M.L

Read more →
Published at

Oct 10, 2024 6:34 PM

by insurancejournal.com

positive

positive

J&J’s Court-Shopping Strategy Pits New Jersey Home Against Texas

Johnson & Johnson's bold move to skirt a US court in New Jersey and seek a potentially friendlier venue in Texas to settle claims its baby powder gave

SRNE JNJ DJNJ3.BA DJNJ2.BA 0L85.L

Read more →
Published at

Aug 27, 2024 2:49 PM

by globenewswire.com

mixed

mixed

By 2034, CAR-T Cell Therapy Market Set to Soar USD 8.7 Billion, at 1.80% CAGR: Prophecy Market Insights

“CAR-T Cell Therapy Market” from 2024-2034 with covered segments By Drug Type (Ciloleucel, Axicabtagene, Brexucabtagene Autoleucel, Tisagenlecleucel, and...

SRNE 0L85.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK BLUE.MX BLUE 6MK.DE 0K9E.L 0HOH.L

Read more →
Published at

Jun 10, 2024 5:02 PM

by globenewswire.com

positive

positive

CAR-T Cell Therapy Market to Achieve USD 85.8 Billion by 2033, Driven by 32.0% CAGR | Dimension Market Research

Advancements and Projections in the CAR-T Cell Therapy Market: Insights, Trends, Opportunities, and Recent Developments...

SRNE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ GIS.DE GILDD.BA GILD.MX GILD DJNJ3.BA DJNJ2.BA CAHD.BA BRM.DE BMYB34.SA BMY.MX BMY.BA BMY 0L85.L 0K9E.L

Read more →
Published at

Apr 18, 2024 8:00 PM

by globenewswire.com

mixed

mixed

Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72%

The Global CAR T-Cell Therapy Market Size was Valued at USD 4.29 Billion in 2023 and the Worldwide CAR T-Cell Therapy Market Size is Expected to Reach USD...

SRNE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA GIS.DE GILDD.BA GILD.MX GILD BRM.DE BMYB34.SA BMY.MX BMY.BA BMY 0L85.L 0K9E.L MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ DJNJ3.BA DJNJ2.BA BLUE.MX BLUE 6MK.DE 0HOH.L

Read more →
Published at

Mar 26, 2024 12:32 PM

by marketscreener.com

mixed

mixed

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax® Pharmaceuticals, Inc. , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and viral barrier...

SRNE 0L85.L VRPX

Read more →
Published at

Mar 15, 2024 2:56 PM

by investing.com

positive

positive

Scilex reaches settlement in Sorrento bankruptcy case By Investing.com

Scilex reaches settlement in Sorrento bankruptcy case

VRPX SRNE 0L85.L

Read more →
Published at

Mar 15, 2024 2:00 PM

by globenewswire.com

mixed

mixed

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previ

PALO ALTO, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue generating...

VRPX SRNE 0L85.L

Read more →
Published at

Mar 2, 2024 9:25 PM

by benzinga.com

negative

negative

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Sha

PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX,

SRNE 0L85.L

Read more →
Published at

Feb 21, 2024 12:07 PM

by globenewswire.com

mixed

mixed

Oncolytic Virus Immunotherapy Market Expected to Reach USD 572.2 million by 2031, Expanding at a 21.1% CAGR | Transparency Market Research, Inc.

The two main drivers driving up the value of the oncolytic virus immunotherapy market are the rising incidence of cancer and the increase in healthcare...

MBIO CADL ONCR MRKD.BA MRK.SN MRK.PA MRK.MX MRK AMGN.MX AMGN.BA AMGN AMG.DE 6MK.DE SRNE REPL ONCY ONC.TO 4588.T 0L85.L

Read more →
Published at

Feb 14, 2024 11:02 PM

by globenewswire.com

negative

negative

Natural Killer (NK) Cell Therapeutics Market: Pioneering Immunotherapy for Cancer Treatment with market Size & Share to Exceed USD 114119.6 Million by 2034, at CAGR of 41.70% – By PMI

“Natural Killer (NK) Cell Therapeutics Market” from 2024-2034 with covered segments (Natural Killer (NK) Cell Therapeutics Market, By Type (NK Cell...

TKPHF TAKP34.SA TAKN.MX TAK SRNE NK IPHYF IPHA IPH.PA AFMD 4502.T 4502.S 0L85.L 0HL9.L 0A87.L

Read more →
Published at

Oct 12, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight

The marginal zone lymphoma pipeline possesses potential drugs in mid-stage developments to be launched in the near future. The total marginal zone lymphoma...

JNJ GILDD.BA DJNJ3.BA DJNJ2.BA XNCR TGTX STTK STRO SRNE SGEN SDGR PSTX ONCT NRIX NKTR MEIP INCY IGMS I1NC34.SA ESALY ESALF CRIS CLRB BPTH BMEA ACET 4572.T 4523.T 0VGI.L 0UNL.L 0L85.L 0JW9.L 0J9P.L 0HX7.L 0A8R.L 003850.KS

Read more →
Published at

Sep 19, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out - AbbVie, Genmab, Merck, Xencor, Janssen, Roche, Biogen, Regeneron, Seagen, Tak

The DLBCL market has a diverse pipeline, with the emergence of novel classes such as bi-specific antibodies, cancer vaccines, and allogeneic CAR-Ts in the...

SGEN ONCT 0A8R.L TGTX STTK STRO SRNE NRIX NKTR MEIP INCY I1NC34.SA GILDD.BA ESALY ESALF CRIS BMEA ACET 4523.T 0VGI.L 0UNL.L 0L85.L 0JW9.L 0J9P.L 0HX7.L 003850.KS

Read more →
Published at

Aug 23, 2023 10:51 AM

by globenewswire.com

mixed

mixed

Global CAR T-Cell Therapy Market Size on a Meteoric Rise: Envisioning $2406.39 Million by 2030 with a Striking CAGR of 26.20%

[222 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global CAR T-Cell Therapy Market size &...

SRNE PSTX PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA GIS.DE GILDD.BA GILD.MX GILD FBIOP FBIO CYAD CLXT BLUE.MX BLUE AMGN.MX AMGN.BA AMGN AMG.DE 0QFK.L 0L85.L 0K9E.L 0HOH.L IMUN ATRA 0HIY.L

Read more →
Published at

Aug 9, 2023 9:30 AM

by prnewswire.com

mixed

mixed

CAR T-Cell Therapy Market size to grow at a CAGR of 13.44% from 2022 to 2027; Growing Awareness Regarding CAR T-cell Therapy to boost the market growth- Technavio.

/PRNewswire/ -- The CAR T-cell therapy market is expected to grow by USD 1,999 million from 2022 to 2027, progressing at a CAGR of 13.44% as per the latest...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA GSK.L GSK GS7.DE GLAXF 0K9E.L SRNE SGMO GIS.DE GILDD.BA GILD.MX GILD GBY.DE FBIOP FBIO FATE CYAD AUTL ALLO 0R1D.L 0QFK.L 0L85.L TCRR

Read more →
Published at

May 1, 2023 7:00 PM

by globenewswire.com

mixed

mixed

DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM

The introduction of ADCs into the market and the promising clinical results of more ADC prospects have increased industry interest in ADCs as a treatment...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA 4575.T 2696.HK 0Q1G.L TCON SGEN OPHLY OPHLF INCY I1NC34.SA GILDD.BA CMVLF CLLS ASCLF ALCLS.PA 4528.T 1672.HK 0J9P.L 0A8R.L SRNE 0L85.L

Read more →
Published at

Apr 10, 2023 10:05 PM

by benzinga.com

mixed

mixed

Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrant of Core Scientific, Inc. Core Scientific, Inc. securities were suspended on January

VRYYF VERY.V VERY.CN SRNE QTT LHDX CYRN 0L85.L SIOX HYRE

Read more →
Published at

Mar 20, 2023 11:30 AM

by globenewswire.com

positive

positive

AL Amyloidosis Therapeutics Market is projected to rise at a 7.3% CAGR until 2033, being valued at US$ 4.56 billion | Future Market Insights, Inc.

Reaching US$ 4.56 Billion by 2033, AL Amyloidosis Therapeutics to be most Useful for Chemotherapy, commanding over 50% of all Applications. North American...

SRNE SPPI EIDX 0L85.L

Read more →
Published at

Jan 30, 2023 4:27 AM

by globenewswire.com

mixed

mixed

Sorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a “Frequently Asked Questions” document...

YI VCKAW VCKAU VCKA USBC34.SA USB.SN USB.MX USB.BA USB UB5.DE SRNE SNEX NTRSO NTRS MSCL.SN 0LHY.L 0L85.L IBKR

Read more →